Omicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial ...Middle East

Devdiscourse - Opinion
Omicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial
COVID-19 vaccine candidates developed by a Sinopharm subsidiary and Sinovac Biotech to target the Omicron variant were approved for clinical trials in Hong Kong, the companies said on Saturday.

Hence then, the article about omicron specific sinopharm sinovac covid vaccine candidates cleared for clinical trial was published today ( ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Omicron-specific Sinopharm, Sinovac COVID vaccine candidates cleared for clinical trial )

Apple Storegoogle play

Last updated :

Also on site :